SCTIMST & Tata Elxsi Inks Pact to Advance Healthcare Innovation & MedTech Development

SCTIMST & Tata Elxsi Inks Pact to Advance  Healthcare Innovation & MedTech Development

Advertisement

Initial activities will concentrate on identifying high-potential projects that can be jointly developed and translated into solutions for healthcare providers and patients.

Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Kerala, and Tata Elxsi, a global design and technology services company headquartered in Bangalore, have entered into a strategic partnership to accelerate healthcare innovation and medical technology development.

The initiative is expected to provide Tata Elxsi, its customers, and healthcare partners with access to clinicians, specialist researchers, advanced laboratories, prototyping facilities, and product engineering capabilities within a unified ecosystem.

Sreevatsa Sahasranaman, Senior Vice President and Head, Healthcare and Life Sciences, Tata Elxsi, said, “Healthcare innovation increasingly depends on closer collaboration between clinicians, scientists, and engineering teams. Our partnership with SCTIMST brings together complementary strengths across healthcare, technology, and product development to help address evolving healthcare needs.”

“Recognised for its strong research and innovation capabilities, SCTIMST adds significant depth to this collaboration. We believe this partnership will help bring India-led innovation to global healthcare markets," he added.

The partnership will focus on opportunities across healthcare innovation, including diagnostics, medical imaging, digital health, biomedical engineering, medical devices, and related healthcare technologies.

By integrating clinical knowledge with engineering and design expertise, the organizations aim to enable MedTech companies to develop, validate, and scale innovative products more efficiently.

The collaboration will also strengthen capabilities in areas such as biocompatibility testing and toxicology, which are essential for the safe development of medical technologies.

The MoU further establishes a framework for joint research, academic collaboration, technology development initiatives, and intellectual property creation through project-specific engagements.

Initial activities will concentrate on identifying high-potential projects that can be jointly developed and translated into solutions for healthcare providers and patients.

Stay tuned for more such updates on Digital Health News

Follow us

More Articles By This Author


Show All

Sign In / Sign up